Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival

被引:34
作者
Ek, S
Björck, E
Högerkorp, CM
Nordenskjöld, M
Porwit-MacDonald, A
Borrebaeck, CAK
机构
[1] Lund Univ, Dept Immunotechnol, SE-22007 Lund, Sweden
[2] Karolinska Univ Hosp, Dept Mol Med, Stockholm, Sweden
[3] Karolinska Univ Inst, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden
关键词
mantle cell lymphoma; DNA microarray; CCL4; CCL5; 4-1BB-L;
D O I
10.1002/ijc.21579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have analyzed mantle cell lymphomas (MCLs), using highdensity DNA microarrays, and confirmed the expression of differentially regulated antigens, using flow cytometry and immunohistochemistry. The results show that MCLs acquire expression of molecules that normally are involved in interaction with other immune cells and, thus, might affect the ability of the tumor to survive. The MCL signature is represented by the overexpression of the chemokine CCL4 (MIP-1 beta), implicated in the recruitment of regulatory T cells, as well as CCL5 and 4-1BB-L. The latter molecules are normally involved in chemotaxis of T cells and B cell activation, respectively. Signaling through 4-1BB-L allows B cells to proliferate and the expression of its ligand, by the intra-tumoral mesh of follicular dendritic cells (FDC), could thus serve as a paracrine loop facilitating growth and survival of MCL cells. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:2092 / 2097
页数:6
相关论文
共 42 条
[1]   Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma [J].
Abe, M ;
Hiura, K ;
Wilde, J ;
Moriyama, K ;
Hashimoto, T ;
Ozaki, S ;
Wakatsuki, S ;
Kosaka, M ;
Kido, S ;
Inoue, D ;
Matsumoto, T .
BLOOD, 2002, 100 (06) :2195-2202
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]  
Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424
[4]   RANTES: a versatile and controversial chemokine [J].
Appay, V ;
Rowland-Jones, SL .
TRENDS IN IMMUNOLOGY, 2001, 22 (02) :83-87
[5]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[6]   Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations [J].
Camacho, FI ;
Algara, P ;
Rodríguez, A ;
Ruíz-Ballesteros, E ;
Mollejo, M ;
Martínez, N ;
Martínez-Climent, JA ;
González, M ;
Mateo, M ;
Caleo, A ;
Sánchez-Beato, M ;
Menárguez, J ;
García-Conde, J ;
Solé, F ;
Campo, E ;
Piris, MA .
BLOOD, 2003, 101 (10) :4042-4046
[7]  
Chan WC, 1997, BLOOD, V89, P3909
[8]   Discordant protein and mRNA expression in lung adenocarcinomas [J].
Chen, GA ;
Gharib, TG ;
Huang, CC ;
Taylor, JMG ;
Misek, DE ;
Kardia, SLR ;
Giordano, TJ ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, SM ;
Beer, DG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (04) :304-313
[9]   Role of 4-1BB:4-1BB ligand in cancer immunotherapy [J].
Cheuk, ATC ;
Mufti, GJ ;
Guinn, BA .
CANCER GENE THERAPY, 2004, 11 (03) :215-226
[10]   Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma [J].
Ek, S ;
Ortega, E ;
Borrebaeck, CAK .
LEUKEMIA RESEARCH, 2005, 29 (02) :205-213